| Product / Indication | Pre-Clinical | Phase I | Phase II | Phase III | |
|---|---|---|---|---|---|
| rezafungin | |||||
| Prophylaxis* Investigational indication |
Phase III
|
||||
| taurolidine and heparin | |||||
| Total Parenteral Nutrition (TPN) Investigational indication |
Phase III
|
||||
| Hemodialysis (Pediatric) Investigational indication |
Phase III
|
||||
*Study conducted by Mundipharma